ImPACT Applications, Inc

ImPACT Applications, Inc. develops FDA-cleared medical devices for concussion assessment and management. The company's flagship product line—ImPACT, ImPACT Pediatric, and ImPACT Quick Test—comprises the longest-standing FDA-cleared computerized neurocognitive testing platforms designed to evaluate cognitive health, track post-concussion recovery, and support return-to-activity decisions. These assessments measure objective neurocognitive function (memory, processing speed, reaction time, and other cognitive domains) before and after injury, generating data-driven clinical insights. The company serves athletic programs (professional sports leagues, college athletics, youth sports), healthcare systems, urgent care facilities, emergency departments, and sports medicine practices. ImPACT's assessment tools are backed by the largest clinical research database in concussion management and have become the gold standard in neurocognitive baseline testing and post-concussion evaluation. Version 5 represents the latest release. The company offers customized training and virtual instruction for providers to ensure proper administration and interpretation. Primary markets include the United States across high school, college, and professional sports organizations, military and occupational health settings, and hospital-based concussion clinics.